Atezolizumab and Bevacizumab Combination Therapy and Sequential Conversion Hepatectomy for Advanced Fibrolamellar Hepatocellular Carcinoma Presenting Pseudoprogression
Liver Cancer
.
2022 Oct 25;12(2):180-183.
doi: 10.1159/000527250.
eCollection 2023 Jun.
Authors
Ryota Matsuki
1
,
Naohiro Okano
2
,
Nobuhiro Hasui
1
,
Shohei Kawaguchi
1
,
Hirokazu Momose
1
,
Keiichiro Kitahama
3
,
Kiyotaka Nagahama
3
,
Masaharu Kogure
1
,
Yutaka Suzuki
1
,
Fumio Nagashima
2
,
Junji Shibahara
3
,
Hideaki Mori
4
,
Yoshihiro Sakamoto
1
Affiliations
1
Department of Hepato-Biliary-Pancreatic Surgery, Kyorin University Hospital, Tokyo, Japan.
2
Department of Medical Oncology, Kyorin University Faculty of Medicine, Tokyo, Japan.
3
Department of Pathology, Kyorin University School of Medicine, Tokyo, Japan.
4
Department of Hepatology and Gastroenterology, Kyorin University Faculty of Medicine, Tokyo, Japan.
PMID:
37325496
PMCID:
PMC10267524
DOI:
10.1159/000527250
No abstract available
Grants and funding
There were no funding sources for this manuscript.